Mariposa Bioscience, Inc. was founded in mid 2006 by Robert
Pytela and Jacinto Villanueva. Mariposa
Bioscience has developed, and now firmly established, a new technology for
obtaining monoclonal antibodies directly from peripheral blood B cells of
non-rodent species (primarily rabbit and chicken). The company’s business has
focused on contract antibody development, primarily for major suppliers in the
immunohistochemistry/in vitro diagnostics field, as well for university
laboratories. In addition, Mariposa Bioscience is also actively pursuing in-house
research and development, focusing on further technology improvement,
high-throughput antibody development, and discovery of antibodies against novel
cancer bio-markers for research, diagnostic and therapeutic purposes.